Comparability of self-reported medication use and pharmacy claims data
Archived Content
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please "contact us" to request a format other than those available.
1. Gama H, Correia S, Lunet N. Questionnaire design and the recall of pharmacological treatments: a systematic review. Pharmacoepidemiology and Drug Safety 2009; (3): 175-87.
2. Johnson RE, Vollmer WM. Comparing sources of drug data about the elderly. Journal of the American Geriatrics Society 1991; 39(11): 1079-84.
3. Klungel OH, de Boer A, Paes AH, et al. Influence of question structure on the recall of self-reported drug use. Journal of Clinical Epidemiology 2000; 53(3): 273-7.
4. Boudreau DM, Daling JR, Malone KE, et al. A validation study of patient interview data and pharmacy records for antihypertensive, statin, and antidepressant medication use among older women. American Journal of Epidemiology 2004; 159(3): 308-17.
5. Paganini-Hill A, Ross RK. Reliability of recall of drug usage and other health-related information. American Journal of Epidemiology 1982; 116(1): 114-22.
6. Boudreau DM, Doescher MP, Saver BG, et al. Reliability of Group Health Cooperative automated pharmacy data by drug benefit status. Pharmacoepidemiology and Drug Safety 2005; 14(12): 877-84.
7. Pit S, Byles J. Older Australians' medication use: self-report by phone showed good agreement and accuracy compared with home visit. Journal of Clinical Epidemiology 2010; 63(4): 428-34.
8. Pit SW, Byles JE, Cockburn J. Accuracy of telephone self-report of drug use in older people and agreement with pharmaceutical claims data. Drugs and Aging 2008; 25(1): 71-80.
9. West SL, Strom BL, Poole CH. Validity of pharmacoepidemiologic drug and diagnostics data. In: Strom BL, ed. Pharmacoepidemiology. West Sussex: John Wiley and Sons Ltd., 2006: 709-67.
10. Nielsen MW, Sondergaard B, Kjoller M, Hansen EH. Agreement between self-reported data on medicine use and prescription records vary according to method of analysis and therapeutic group. Journal of Clinical Epidemiology 2008; 61: 919-24.
11. Levy AR, O'Brien BJ, Sellors C, et al. Coding accuracy of administrative drug claims in the Ontario Drug Benefit database. Canadian Journal of Clinical Pharmacology 2003; 10(2): 67-71.
12. Zhong H. Equity in pharmaceutical utilization in Ontario: a cross-section and over time analysis. Canadian Public Policy 2007; 33(4): 487-506.
13. Statistics Canada. Bootvar: User Guide (Bootvar 3.1- SAS Version) Ottawa: Statistics Canada, 2005.
14. Altman DG. Practical Statistics for Medical Research. London: Chapman and Hall, 1991.
15. Roberts RO, Bergstralh EJ, Schmidt I, Jacobsen SJ. Comparison of self-reported and medical record health care utilisation measures. Journal of Clinical Epidemiology 1996; 49: 989-95.
16. Raina P, Torrance-Rynard V, Wong M, Woodward C. Agreement between self-reported and routinely collected health-care utilization data among seniors. Health Services Research 2002; 37(3): 751-74.
17. Muhajarine N, Mustard C, Roos LL, et al. Comparison of survey and physician claims data for detecting hypertension. Journal of Clinical Epidemiology 1997; 50(6): 711-8.
18. Tu K, Campbell NRC, Chen Z-L, et al. Accuracy of administrative databases in identifying patients with hypertension. Open Medicine 2007; 1(1): E18-26.
19. Johnston DW, Propper C, Shields MA. Comparing subjective and objective measures of health: Evidence from hypertension for the income/health gradient. Journal of Health Economics 2009; 28(3): 540-52.
20. Danon-Hersch N, Marques-Vidal P, Bovet P, et al. Prevalence, awareness, treatment and control of high blood pressure in a Swiss city general population: the CoLaus study. European Journal of Cardiovascular Prevention and Rehabilitation 2009; 16(1): 66-72.
21. Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. American Journal of Hypertension 2006; 19(11): 1190-6.
22. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. Journal of the American Medical Assoication 2002; 288(4): 462-7.
23. Haynes RB, Ackloo E, Sahota N, et al. Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews 2008; 2(CD000011):DOI: 10.1002/14651858.CD000011.pub3.
24. Svensson S, Kjellgren KI, Ahlner J, Saljo R. Reasons for adherence with antihypertensive medication. International Journal of Cardiology 2000; 76(2-3): 157-63.
25. Osterberg L, Blaschke T. Adherence to medication. New England Journal of Medicine 2005; 353(5): 487-97.
26. Berk ML, Schur CL, Mohr P. Using survey data to estimate prescription drug costs. Health Affairs 1990; 9(3): 146-56.
27. Anderson JG, Taylor AG. Use of complementary therapies by individuals with or at risk for cardiovascular disease: results of the 2007 National Health Interview Survey. Journal of Cardiovascular Nursing 2012; 27(2): 96-102.
28. Paterson JM, Suleiman A, Hux JE, Bell C. How complete are drug history profiles that are based on public drug benefit claims? Canadian Journal of Clinical Pharmacology 2008; 15(1): e108-16.
- Date modified: